T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation

Nature Immunology

Volumn 5, Issue 8, 2004, Pages 818-827

  Jackson, Sharon H ^a   Devadas, Satish ^b,e   Kwon, Jaeyul ^b,d   Pinto, Ligia A ^c   Williams, Mark S ^b,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOLLAND LABORATORY   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEFICIENCY; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; CELLS, CULTURED; FAS LIGAND PROTEIN; HUMANS; IMMUNOBLOTTING; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 4444221709     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1096     Document Type: Article

References (52)

1. Babior, B.M. NADPH oxidase: an update. Blood 93, 1464-1476 (1999).
2. Segal, B.H., Leto, T.L., Gallin, J.I., Malech, H.L. & Holland, S.M. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79, 170-200 (2000).
3. Pollock, J.D. et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9, 202-209 (1995).
4. phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182, 751-758 (1995).
5. Yang, S., Panoskaltsis-Mortari, A., Shukla, M., Blazar, B.R. & Haddad, I.Y. Exuberant inflammation in nicotinamide adenine dinucleotide phosphate-oxidase-deficient mice after allogeneic marrow transplantation. J. Immunol. 168, 5840-5847 (2002).
6. Nathan, C. & Shiloh, M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97, 8841-8848 (2000).
7. Ushio-Fukai, M. et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 274, 22699-226704 (1999).
8. Bae, Y.S. et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221 (1997).
9. 2 for platelet-derived growth factor signal transduction. Science 270, 296-299 (1995).
10. Lee, S.L., Wang, W.W., Finlay, G.A. & Fanburg, B.L. Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am. J. Physiol. 277, L282-L291 (1999).
11. 2-terminal kinases. J. Biol. Chem. 271, 15703-15707 (1996).
12. 2-generating system present in human fat-cell plasma membranes is multireceptor-linked and under antagonistic control by hormones and cytokines. Biochem. J. 307, 543-548 (1995).
13. Lee, J.R. & Koretzky, G.A. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur. J. Immunol. 28, 4188-4197 (1998).
14. Sundaresan, M. et al. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318, 379-382 (1996).
15. Jayanthi, S., Ordonez, S., McCoy, M.T. & Cadet, J.L. Dual mechanism of Fas-induced cell death in neuroglioma cells: a role for reactive oxygen species. Brain Res. Mol. Brain Res. 72, 158-165 (1999).
16. Condino-Neto, A. & Newburger, P.E. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Arch. Biochem. Biophys. 360, 158-164 (1998).
17. Frey, R.S., Rahman, A., Kefer, J.C., Minshall, R.D. & Malik, A.B. PKCz regulates TNF-a-induced activation of NADPH oxidase in endothelial cells. Circ. Res. 90, 1012-1019 (2002).
18. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105, 293-296 (2002).
19. Griendling, K.K., Sorescu, D. & Ushio-Fukai, M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501 (2000).
20. phox homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894 (2001).
21. Banfi, B., Clark, R.A., Steger, K. & Krause, K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510-3513 (2003).
22. Devadas, S., Zaritskaya, L., Rhee, S.G., Oberley, L. & Williams, M.S. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195, 59-70 (2002).
23. van Reyk, D.M., King, N.J., Dinauer, M.C. & Hunt, N.H. The intracellular oxidation of 2′,7′-dichlorofluorescein in murine T lymphocytes. Free Radic. Biol. Med. 30, 82-88 (2001).
24. Kwon, J., Devadas, S. & Williams, M.S. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation. Free Radic. Biol. Med. 35, 406-417 (2003).
25. Williams, M.S. & Henkart, P.A. The role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157, 2395-2402 (1996).
26. Hasebe, T., Someya, A. & Nagaoka, I. Identification of a splice variant mRNA of p40phox, an NADPH oxidase component of phagocytes. FEBS Lett. 455, 257-261 (1999).
27. Lomax, K.L., Leto, T.L., Nunoi, H., Gallin, J.I. & Malech, H.L. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245, 409-412 (1989).
28. Emmendorffer, A. et al. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 18, 147-155 (1994).
29. phox. Microbiol. Immunol. 45, 249-257 (2001).
30. Li, J.M. & Shah, A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277, 19952-19960 (2002).
31. Maly, F.E. et al. Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. J. Immunol. 142, 1260-1267 (1989).
32. Bossi, G. & Griffiths, G.M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5, 90-96 (1999).
33. Martinez-Lorenzo, M.J. et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163, 1274-1281 (1999).
34. 2-terminal kinase. J. Exp. Med. 191, 1017-1030 (2000).
35. Ju, S.T. et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448 (1995).
36. Williams, M.S. & Kwon, J. T cell receptor stimulation, reactive oxygen species and cell signaling. Free Radic. Biol. Med. advance online publication, 20 June 2004 (do:10.016/j.freeradbiomed.2004.05.029).
37. Suzuki, Y., Ono, Y. & Hirabayashi, Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett. 425, 209-212 (1998).
38. phox in the activation and expression of the human respiratory burst NADPH oxidase. J. Biochem. (Tokyo) 128, 777-783 (2000).
39. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest. 89, 1006-1013 (1992).
40. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor b1. J. Biol. Chem. 270, 30334-30338 (1995).
41. 2 and plays an integral role in insulin signal transduction. Mol. Cell Biol. 24, 1844-1854 (2004).
42. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K. & Leto, T.L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17, 1502-1504 (2003).
43. phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J. Biol. Chem. 277, 45181-45187 (2002).
44. Lambeth, J.D. Nox enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189 (2004).
45. Esposti, M.D., Hatzinisiriou, I., McLennan, H. & Ralph, S. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J. Biol. Chem. 274, 29831-29837 (1999).
46. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276, 37594-37601 (2001).
47. phox, a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase. J. Immunol. 172, 231-239 (2004).
48. Martinez-Lorenzo, M.J., Alava, M.A., Anel, A., Pineiro, A. & Naval, J. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89, 511-517 (1996).
49. Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43 (1995).
50. Seshiah, P.N. et al. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91, 406-413 (2002).
51. + T cells. J. Immunol. 170, 2427-2434 (2003).
52. phox-/- mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect. Immun. 67, 1659-1665 (1999).